SCHEMBL6620076

SCHEMBL6620076

COc1cccc(-c2cnc3cc4cn[nH]c4cc3n2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 1/20 0.48
▸ FGFR2 P21802 1/20 0.48
▸ FGFR3 P22607 1/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ GLA P06280 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48
▸ PDGFRB P09619 2/20 0.47
▸ PDGFRA P16234 1/20 0.47
▸ TGFBR1 P36897 1/20 0.44
▸ ROCK2 O75116 3/20 0.44
▸ TOP1 P11387 1/20 0.44
▸ RAF1 P04049 2/20 0.43
▸ BRAF P15056 2/20 0.43
▸ PIK3CA P42336 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ SYK P43405 1/20 0.43
▸ AURKA O14965 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6616674 1.00 FGFR1 (0.48) FGFR1FGFR2FGFR3SMN1; SMN2ALDH1A1
SCHEMBL6618733 0.88 FGFR2 (0.65) FGFR1FGFR2FGFR3SMN1; SMN2ALDH1A1
SCHEMBL8116664 0.88 FGFR2 (0.65) FGFR1FGFR2FGFR3SMN1; SMN2ALDH1A1
SCHEMBL6617504 0.88 FGFR2 (0.65) FGFR1FGFR2FGFR3SMN1; SMN2ALDH1A1
SCHEMBL6622035 0.87 GAA (0.44) FGFR1FGFR2FGFR3SMN1; SMN2ALDH1A1
SCHEMBL6618516 0.87 GAA (0.44) FGFR1FGFR2FGFR3SMN1; SMN2ALDH1A1
SCHEMBL6618338 0.86 MAPK1 (0.51) SMN1; SMN2ALDH1A1GLAGAAMAPT
SCHEMBL6617606 0.86 MAPK1 (0.51) SMN1; SMN2ALDH1A1GLAGAAMAPT
SCHEMBL8112499 0.86 MAPK1 (0.51) SMN1; SMN2ALDH1A1GLAGAAMAPT
SCHEMBL9133005 0.84 FGFR2 (0.57) FGFR1FGFR2FGFR3SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE AVENTIS PHARMA INC (US) 2004-06-23 — — EP disclosed
EP-0779889-A4 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE POULENC RORER PHARMA (US) 2000-02-23 — — EP disclosed
EP-0779889-A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1997-06-25 — — EP disclosed
WO-1996007658-A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-03-14 — — WO disclosed
US-5476851-A Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1995-12-19 — — US disclosed
Send feedback